News

GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial.
Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and his ...
Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis.
Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.
Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy for everything.
In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency after six weeks.
A Phase 2 clinical trial has begun recruiting that’s assessing the safety and efficacy of LTI-03, Rein Therapeutics ’ inhaled therapy for idiopathic pulmonary fibrosis (IPF).
Ipilimumab, a cancer immunotherapy, reduced scar formation and promoted tissue regeneration in a mouse model of idiopathic pulmonary fibrosis.
Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.
Looking for information on oxygen therapy for pulmonary fibrosis? Read about how and why oxygen therapy is used in IPF.